CSIMarket
 


Organogenesis Holdings Inc   (ORGO)
Other Ticker:  
 

Cumulative Organogenesis Holdings Inc 's Total Debt to Equity for Trailing Twelve Months Period

ORGO's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

ORGO Total Debt to Equity for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Growth 35.5 % 42.18 % 54.63 % 65.68 % 188.93 %
Y / Y Total Debt Growth -10.4 % 206.35 % 199.33 % 192.99 % 47.15 %
Total Debt to Equity for Trailing Twelve Months Period 0.29 0.32 0.29 0.26 0.23
Total Ranking # 584 # 877 # 947 # 1052 # 1026
Seq. Equity Growth 0.76 % 4.59 % 0.49 % 27.94 % 5.73 %
Seq. Total Debt Growth 0.05 % -0.59 % -0.59 % -9.38 % 242.08 %


Total Debt to Equity for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite net new borrowings of 0.05% Organogenesis Holdings Inc managed to decrease Total Debt to Equity for Trailing Twelve Months Period in III. Quarter to 0.29, above Organogenesis Holdings Inc 's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 42 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Organogenesis Holdings Inc . While Total Debt to Equity for Trailing Twelve Months Period total ranking has improved so far to 584, from total ranking in previous quarter at 877.

What is Debt to Equity Ratio?
ORGO Charts and Quotes
Total Debt to Equity ORGO in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 43
Sector # 133
S&P 500 # 583


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.13 0.06 0.01
(Jun 30 2019)   (Sep 30 2022)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Total Debt to Equity for Trailing Twelve Months Period
Statera Biopharma Inc fka Cytocom Inc   0.79 
Biovie Inc   0.78 
Mallinckrodt Plc  0.78 
Zogenix Inc   0.78 
Merck and Co Inc   0.75 
Perrigo Company Plc  0.74 
Dynavax Technologies Corporation  0.73 
Ironwood Pharmaceuticals inc   0.73 
Ocular Therapeutix Inc   0.72 
Zealand Pharma A  0.72 
Royalty Pharma Plc  0.69 
Chembio Diagnostics Inc   0.63 
Sunwin Stevia International Inc.  0.63 
Assertio Holdings inc   0.61 
G1 Therapeutics Inc   0.59 
Emergent Biosolutions Inc   0.58 
Selecta Biosciences Inc  0.58 
Cryoport inc   0.55 
Horizon Therapeutics Public Limited Company  0.54 
Adc Therapeutics Sa  0.52 
Pfizer Inc  0.49 
Abbott Laboratories  0.49 
Alaunos Therapeutics Inc   0.48 
Ardelyx inc   0.48 
Supernus Pharmaceuticals inc   0.47 
Skye Bioscience Inc   0.46 
Syros Pharmaceuticals Inc   0.46 
Johnson and Johnson  0.45 
Eton Pharmaceuticals Inc   0.45 
Durect Corp  0.43 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PDLB's Profile

Stock Price

PDLB's Financials

Business Description

Fundamentals

Charts & Quotes

PDLB's News

Suppliers

PDLB's Competitors

Customers & Markets

Economic Indicators

PDLB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071